A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives ; volume:43 ; number:5 ; day:22 ; month:3 ; year:2024 ; pages:959-968 ; date:5.2024
European journal of clinical microbiology & infectious diseases ; 43, Heft 5 (22.3.2024), 959-968, 5.2024

Creator: Oldendorff, Frida
Nordberg, Viveka
Giske, Christian G.
Navér, Lars

Contributor: SpringerLink (Online service)

DOI: 10.1007/s10096-024-04809-8

URN: urn:nbn:de:101:1-2407310953516.726680643104

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Oldendorff, Frida
Nordberg, Viveka
Giske, Christian G.
Navér, Lars
SpringerLink (Online service)

Other Objects (12)

Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens

Vaccine antigen identification against dangerous Gram-positive ESKAPE pathogens

Cortactin: A universal host cytoskeletal target of Gram‐negative and Gram‐positive bacterial pathogens

Oritavancin as sequential therapy for Gram-positive bloodstream infections

Nanoparticle targeting of Gram-positive and Gram-negative bacteria for magnetic-based separations of bacterial pathogens

Selenocompounds as Potent Efflux Pump Inhibitors on Gram‐positive Bacteria

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens

Cytokine induction by Gram-positive bacteria

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Morphological and cytokine profiles as key parameters to distinguish between Gram-negative and Gram-positive bacterial keratitis

Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens

Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens

Vaccine antigen identification against dangerous Gram-positive ESKAPE pathogens

Cortactin: A universal host cytoskeletal target of Gram‐negative and Gram‐positive bacterial pathogens

Oritavancin as sequential therapy for Gram-positive bloodstream infections

Nanoparticle targeting of Gram-positive and Gram-negative bacteria for magnetic-based separations of bacterial pathogens

Selenocompounds as Potent Efflux Pump Inhibitors on Gram‐positive Bacteria

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens

Cytokine induction by Gram-positive bacteria

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Morphological and cytokine profiles as key parameters to distinguish between Gram-negative and Gram-positive bacterial keratitis

Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens

Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens

Vaccine antigen identification against dangerous Gram-positive ESKAPE pathogens

Cortactin: A universal host cytoskeletal target of Gram‐negative and Gram‐positive bacterial pathogens

Oritavancin as sequential therapy for Gram-positive bloodstream infections

Nanoparticle targeting of Gram-positive and Gram-negative bacteria for magnetic-based separations of bacterial pathogens

Selenocompounds as Potent Efflux Pump Inhibitors on Gram‐positive Bacteria

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens

Cytokine induction by Gram-positive bacteria

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Morphological and cytokine profiles as key parameters to distinguish between Gram-negative and Gram-positive bacterial keratitis

Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens

Vaccine antigen identification against dangerous Gram-positive ESKAPE pathogens

Cortactin: A universal host cytoskeletal target of Gram‐negative and Gram‐positive bacterial pathogens

Oritavancin as sequential therapy for Gram-positive bloodstream infections

Nanoparticle targeting of Gram-positive and Gram-negative bacteria for magnetic-based separations of bacterial pathogens

Selenocompounds as Potent Efflux Pump Inhibitors on Gram‐positive Bacteria

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens

Cytokine induction by Gram-positive bacteria

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Morphological and cytokine profiles as key parameters to distinguish between Gram-negative and Gram-positive bacterial keratitis

Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens

Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens

Vaccine antigen identification against dangerous Gram-positive ESKAPE pathogens

Cortactin: A universal host cytoskeletal target of Gram‐negative and Gram‐positive bacterial pathogens

Oritavancin as sequential therapy for Gram-positive bloodstream infections

Nanoparticle targeting of Gram-positive and Gram-negative bacteria for magnetic-based separations of bacterial pathogens

Selenocompounds as Potent Efflux Pump Inhibitors on Gram‐positive Bacteria

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens

Cytokine induction by Gram-positive bacteria

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Morphological and cytokine profiles as key parameters to distinguish between Gram-negative and Gram-positive bacterial keratitis

Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens

Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens

Vaccine antigen identification against dangerous Gram-positive ESKAPE pathogens

Cortactin: A universal host cytoskeletal target of Gram‐negative and Gram‐positive bacterial pathogens

Oritavancin as sequential therapy for Gram-positive bloodstream infections

Nanoparticle targeting of Gram-positive and Gram-negative bacteria for magnetic-based separations of bacterial pathogens

Selenocompounds as Potent Efflux Pump Inhibitors on Gram‐positive Bacteria

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens

Cytokine induction by Gram-positive bacteria

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Morphological and cytokine profiles as key parameters to distinguish between Gram-negative and Gram-positive bacterial keratitis

Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens

Related objects

Reset password